507
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Multivariate analysis for optimization and validation of the industrial tablet-manufacturing process

&
Pages 61-71 | Received 26 Aug 2020, Accepted 05 Nov 2020, Published online: 30 Nov 2020

References

  • Mishra V , Thakur S , Patil A , et al. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin Drug Deliv. 2018;15(8):737–758.
  • Pharmaceutical Development Q8(R2): International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use [Internet]; 2009. [cited 2020 May 30]. Available from: https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf.
  • Azari K , Lauzon-Gauthier J , Tessier J , et al. Establishing multivariate specification regions for raw materials using SMB-PLS. IFAC-PapersOnLine. 2015;48(8):1132–1137.
  • Ferreira AP , Tobyn M. Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era. Pharm Dev Technol. 2015;20(5):513–527.
  • Matero S , van den Berg F , Poutiainen S , et al. Towards better process understanding: chemometrics and multivariate measurements in manufacturing of solid dosage forms. J Pharm Sci. 2013;102(5):1385–1403.
  • Adeleye OA. Relationship between compression pressure, mechanical strength and release properties of tablets. Polim Med. 2019;49(1):27–33.
  • Teng Y , Qiu Z , Wen H. Systematical approach of formulation and process development using roller compaction. Eur J Pharm Biopharm. 2009;73(2):219–229.
  • Patel S , Kaushal AM , Bansal AK. Compression physics in the formulation development of tablets. Crit Rev Ther Drug Carrier Syst. 2006;23(1):1–65.
  • Li F , Meyer RF , Chern R. Understanding critical parameters in roller compaction process and development of a novel scaling method. In: 2006 Spring Meeting & 2nd Global Congress on Process Safety proceedings (203c). 2006 [Cited 2020 May 30]. Available from: https://www.aiche.org/conferences/aiche-spring-meeting-and-global-congress-on-process-safety/2006/proceeding/paper/203c-understanding-critical-parameters-roller-compaction-process-and-development-novel-scaling
  • Muteki K , Swaminathan V , Sekulic SS , et al. De-risking pharmaceutical tablet manufacture through process understanding, latent variable modeling, and optimization technologies. AAPS PharmSciTech. 2011;12(4):1324–1334.
  • Liu Z , Bruwer M-J , MacGregor JF , et al. Modeling and optimization of a tablet manufacturing line. J Pharm Innov. 2011;6(3):170–180.
  • Soh JLP , Wang F , Boersen N , et al. Utility of multivariate analysis in modeling the effects of raw material properties and operating parameters on granule and ribbon properties prepared in roller compaction. Drug Dev Ind Pharm. 2008;34(10):1022–1035.
  • Gupte A , DeHart M , Stagner WC , et al. Comparative binder efficiency modeling of dry granulation binders using roller compaction. Drug Dev Ind Pharm. 2017;43(4):574–583.
  • Peeters E , Silva AFT , Fonteyne M , et al. Influence of extended dwell time during pre- and main compression on the properties of ibuprofen tablets. Eur J Pharm Biopharm. 2018;128:300–315.
  • Matji A , Donato N , Gagol A , et al. Predicting the critical quality attributes of ibuprofen tablets via modeling of process parameters for roller compaction and tableting. Int J Pharm. 2019;565:209–218.
  • Rocksloh K , Rapp FR , Abu Abed S , et al. Optimization of crushing strength and disintegration time of a high-dose plant extract tablet by neural networks. Drug Dev Ind Pharm. 1999;25(9):1015–1025.
  • Amidon GL , Lennernas H , Shah VP , et al. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995-backstory of BCS . Aaps J. 2014;16(5):894–898.
  • USP42-NF37. 2019. Dissolution. United States Pharmacopeia, USP-NF online <711>. USP42-NF37 , pp. 6870.
  • USP42-NF37. 2019. Powder fineness. United States Pharmacopeia, USP-NF online <811>. USP42-NF37 , pp. 7024.
  • EudraLex Volume 4, EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation Brussels: European Commission [Internet] ; 2015. [cited 2020 May 30]. Available from: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-4/2015-10_annex15.pdf.
  • Guideline on process validation for finished products - information and data to be provided in regulatory submissions London (UK): European Medicines Agency [Internet] ; 2016. [cited 2020 May 30]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-process-validation-finished-products-information-data-be-provided-regulatory-submissions_en.pdf.
  • Eriksson L , Johansson E , Kettaneh-Wold N , et al. Multi- and megavariate data analysis - Part I Basic Principles and Applications. Umeå (Sweden): Umetrics AB. 2006; Chapter 4, PLS :63–101.
  • Zhao N , Augsburger LL. The influence of product brand-to-brand variability on superdisintegrant Performance. A case study with croscarmellose sodium. Pharm Dev Technol. 2006;11(2):179–185.
  • Guest R. Croscarmellose sodium. In: Rowe R , Sheskey P , Owen S , editors. Handbook of Pharmaceutical Excipients. London (UK): Pharmaceutical Press and American Pharmacists Association; 2006. p. 211–213.
  • Dilebo J , Gabriel T , An overview of factors affecting superdisintegrants functionalities. (IJPSN)). 2019;12(1):4355–4361.
  • Quodbach J , Kleinebudde P. Systematic classification of tablet disintegrants by water uptake and force development kinetics. J Pharm Pharmacol. 2014;66(10):1429–1438.
  • Bele MH , Derle DV. Brand to brand variation in the disintegrant functionality of polacrilin potassium. NF. J Excipients and Food Chem. 2011;2(3):53–63.
  • Zarmpi P , Flanagan T , Meehan E , et al. Biopharmaceutical aspects and implications of excipient variability in drug product performance. Eur J Pharm Biopharm. 2017;111:1–15.
  • Magnesium stearate . European Pharmacopoeia. 10th ed. Strasbourg: Council of Europe; 2019. p. 3163–3165.
  • Jójárt I , Sovány T , Pintye-Hódi K , et al. study of the behavior of magnesium stearate with different specific surface areas on the surface of particles during mixing. J Adhes Sci Technol. 2012;26(24):2737–2744.
  • Thoorens G , Krier F , Leclercq B , et al. Microcrystalline cellulose, a direct compression binder in a quality by design environment-a review. Int J Pharm. 2014;473(1-2):64–72.
  • Galicher LY. Cellulose, Microcrystalline. In: Rowe R , Sheskey P , Owen S , editors. Handbook of Pharmaceutical Excipients. London (UK): Pharmaceutical Press and American Pharmacists Association; 2006. p. 132–135.
  • Vidovic S , Horvat M , Bizjak A , et al. Elucidating molecular properties of kappa-carrageenan as critical material attributes contributing to drug dissolution from pellets with a multivariate approach. Int J Pharm. 2019;566:662–673.
  • USP42-NF37. 2019. Powder flow. United States Pharmacopeia, USP-NF online <1174>. USP42-NF37 , pp. 7871.
  • Srikant P , Akash J , Makesh D , et al. Roller compaction design and critical parameters in drug formulation and development: review. Int J Pharmtech Res. 2015;7(1):90–98.
  • Tye CK , Sun CC , Amidon GE. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J Pharm Sci. 2005;94(3):465–472.
  • Patel AR , Vavia PR. Evaluation of synthesized cross linked polyvinyl alcohol as potential disintegrant. J Pharm Pharm Sci. 2010;13(2):114–127.
  • Sinka IC , Motazedian F , Cocks ACF , et al. The effect of processing parameters on pharmaceutical tablet properties. Powder Technol. 2009;189(2):276–284.
  • Narang AS , Rao VM , Guo H , et al. Effect of force feeder on tablet strength during compression. Int J Pharm. 2010;401(1-2):7–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.